Thursday, October 13, 2016

Dioralyte Relief Raspberry and Blackcurrant





1. Name Of The Medicinal Product



Dioralyte Relief Raspberry



Dioralyte Relief Blackcurrant


2. Qualitative And Quantitative Composition



Active ingredients per sachet:












Pre-cooked Rice Powder




6g




Sodium Citrate PhEur




580mg




Sodium Chloride PhEur




350mg




Potassium Chloride PhEur




300mg



3. Pharmaceutical Form



Sachet containing powder for mixing with water prior to administration.



4. Clinical Particulars



4.1 Therapeutic Indications



For the treatment of fluid and electrolyte loss associated with acute diarrhoea.



4.2 Posology And Method Of Administration



Posology



Adults and children:



One sachet after every loose motion up to a maximum of 5 sachets per day for 3-4 days.



Infants from 3 months to one year under medical advice:



In the event of diarrhoea and depending on the extent of dehydration (loss of weight assessed at less than 10%) 150 to 200 ml/kg/24 hours of preparation may be given.



•   half the volume is to be given during the first 8 hours, and the other half during the next 16 hours.



•   in the event of vomiting accompanying the diarrhoea, the amount administered can be divided up (5 to 10 ml every 5 minutes) and this may be gradually increased until the infant can drink normally.



Method of Administration



Pour the contents of one sachet into a large glass. Add 200ml of drinking water. Mix well until the liquid has a milky appearance and drink the whole glassful Ensure that no solid is remaining at the bottom of the glass and do not use extra water to rinse out the glass. For infants and where drinking water is not available, the water should be freshly boiled and cooled. The solution should be made up immediately before use.



4.3 Contraindications



Dioralyte Relief should not be used in patients with phenylketonuria. However, there may be a number of conditions where treatment with Dioralyte Relief may be inappropriate, e.g. intestinal obstruction requiring surgical intervention, cases of severe renal or hepatic impairment.



4.4 Special Warnings And Precautions For Use



For oral administration only. Dioralyte Relief should not be reconstituted in diluents other than water.



Each sachet should always be dissolved in 200ml water.



Dioralyte Relief should not be administered to infants under 3 months and for those aged 3 months to 1 year, administered under medical advice.



Infants under the age of 2 with diarrhoea should be seen by the physician as soon as possible.



If diarrhoea persists unremittingly for longer than 36 hours the patient should be reassessed by the physician.



No specific precautions are necessary in the elderly. However, care should be taken when administering Dioralyte Relief solution in cases of severe renal or hepatic impairment or other conditions where normal electrolyte balance may be disturbed. Dioralyte Rlief should not be used for self-treatment by patients on low potassium or sodium diets. The use of Dioralyte Relief in patients with these conditions should be supervised by a physician.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



Dioralyte Relief is not contraindicated in pregnancy or lactation but should be used on medical advice.



4.7 Effects On Ability To Drive And Use Machines



Dioralyte Relief could not be expected to affect the ability to drive or use machines.



4.8 Undesirable Effects



None known.



4.9 Overdose



In the event of significant overdose, serum electrolytes should be evaluated as soon as possible, appropriate steps taken to correct any abnormalities and levels monitored until return to normal levels is established. This is particularly important in the very young.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Dioralyte Relief contains a balanced amount of electrolytes, starch and proteins in water. Oral rehydration therapy with Dioralyte Relief enables a dehydrated subject to be rehydrated rapidly. The presence of pre-cooked rice in the formulation enables watery stools to return to normal more rapidly.



The advantages of Dioralyte Relief are bound with its composition.



Water: the appropriate amount is essential to correct dehydration.



Starch: low osmotic capacity (unlike pure glucose) thus preventing any additional loss of fluid through the stools. Rice starch contains 20% amylose and 80% amylopectin.



Proteins: specific nutritional properties.



Electrolytes: essential for restoring the ionic equilibrium. The role of citrate is to correct the acidosis that occurs as a result of diarrhoea. Citrate also enhances the absorption of Na+ and is more stable than bicarbonate.



5.2 Pharmacokinetic Properties



Content of electrolytes in the reconstituted preparation:














Na+




60 mmol/l




Cl-




50 mmol/l




K+




20 mmol/l




Citrate




10 mmol/l (or 30 meq/l)




Osmolarity




140 mosm/l



5.3 Preclinical Safety Data



Not applicable.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Dioralyte Relief Raspberry: Raspberry Flavour Givaudan 611417E, hypromellose, aspartame, ethanol 96%, purified water



Dioralyte Relief Blackcurrant: Blackcurrant Flavour Firmenich 501017, hypromellose, aspartame, ethanol 96%, purified water



6.2 Incompatibilities



None known.



6.3 Shelf Life



A shelf life of 36 months is given for unopened sachets of the product when stored under the conditions given in section 6.4. Once reconstituted, any solution should be used within one hour, or within 24 hours if stored in a refrigerator.



6.4 Special Precautions For Storage



Store in a dry place under 25oC.



6.5 Nature And Contents Of Container



Carton containing paper/PVDC sachets of Dioralyte Relief Raspberry or Blackcurrant powder. Dioralyte Relief Raspberry or Blackcurrant is available in packs of 6 sachets.



6.6 Special Precautions For Disposal And Other Handling



See section 4.2 for instructions on reconstitution.



7. Marketing Authorisation Holder



Sanofi-aventis



One Onslow Street



Guildford



Surrey



GU1 4YS



UK



8. Marketing Authorisation Number(S)



Dioralyte Relief Raspberry: PL 04425/0280



Dioralyte Relief Blackcurant: PL 04425/0273



9. Date Of First Authorisation/Renewal Of The Authorisation



Dioralyte Relief Raspberry: 19 March 2009



Dioralyte Relief Blackcurant: 9 February 2009



10. Date Of Revision Of The Text



19 March 2009



11 LEGAL CLASSIFICATION


GSL





No comments:

Post a Comment